Study of Milnacipran for the Treatment of Fibromyalgia

Completed · Phase 3

Conditions studied: Fibromyalgia

In brief

Antidepressants of all varieties represent a common form of therapy for many chronic states including fibromyalgia. The majority of antidepressants increase the levels of serotonin or norepinephrine in the central nervous system. Milnacipran is a dual norepinephrine and serotonin reuptake inhibitor and may be effective in the treatment of fibromyalgia.

Key facts

Study ID
NCT00098124
Run by
Forest Laboratories
People needed
1200
Starts
2004-11-01
Expected to finish
2006-12-01
Last updated by the study team
2007-12-24

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.